Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lubsen

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Klinische Wochenschrift|January 1, 1988
[Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct]W Bleifeld, M Verstraete, R W Brower, et al.
British Heart Journal|February 1, 1988
Enzyme tests in the evaluation of thrombolysis in acute myocardial infarctionC de Zwaan, G M Willems, F Vermeer, et al.
European Heart Journal|October 1, 1984
Flecainide: one-year efficacy in patients with chronic ventricular arrhythmiasG Vanhaleweyk, K Balakumaran, J Lubsen, et al.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
Lancet (London, England)|January 30, 1988
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplastyM L Simoons, A E Arnold, A Betriu, et al.
The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.
European Heart Journal|November 1, 1987
Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trialP W Serruys, A E Arnold, R W Brower, et al.
International Journal of Cardiology|July 1, 1985
Left ventricular performance in unstable angina: assessment with radionuclide techniquesE E van der Wall, H J Kerkkamp, J Lubsen, et al.
The Journal of Pediatrics|April 1, 1994
Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studiesM Offringa, P M Bossuyt, J Lubsen, et al.
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Klinische Wochenschrift|January 1, 1988
[Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct]W Bleifeld, M Verstraete, R W Brower, et al.
British Heart Journal|February 1, 1988
Enzyme tests in the evaluation of thrombolysis in acute myocardial infarctionC de Zwaan, G M Willems, F Vermeer, et al.
European Heart Journal|October 1, 1984
Flecainide: one-year efficacy in patients with chronic ventricular arrhythmiasG Vanhaleweyk, K Balakumaran, J Lubsen, et al.
Lancet (London, England)|November 2, 1985
Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarctionM Verstraete, W Bleifeld, R W Brower, et al.
Lancet (London, England)|January 30, 1988
Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplastyM L Simoons, A E Arnold, A Betriu, et al.
The American Journal of Cardiology|August 1, 1987
Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: initial patency and influence of maintained infusion on reocclusion rateM Verstraete, A E Arnold, R W Brower, et al.
European Heart Journal|November 1, 1987
Effect of continued rt-PA administration on the residual stenosis after initially successful recanalization in acute myocardial infarction--a quantitative coronary angiography study of a randomized trialP W Serruys, A E Arnold, R W Brower, et al.
International Journal of Cardiology|July 1, 1985
Left ventricular performance in unstable angina: assessment with radionuclide techniquesE E van der Wall, H J Kerkkamp, J Lubsen, et al.
The Journal of Pediatrics|April 1, 1994
Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studiesM Offringa, P M Bossuyt, J Lubsen, et al.
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.
Pageof 11